We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
UK biotech AKL Research and Development (AKLRD) has received a grant from a UK government-backed innovation body to develop its potentially “game changing” osteoarthritis drug.
The UK Government’s innovation agency Innovate UK has awarded AKL Research and Development (AKLRD) £675,000 linked to the potential of its investigational medicine APPA for osteoarthritis......